1. Gadducci, A, Fabrini, MG, Lanfredini, N, et al. Squamous cell carcinoma of the vagina: natural history, treatment modalities and prognostic factors. Crit Rev Oncol Hematol 2015; 93: 211–224.
Google Scholar | Crossref | Medline2. Shah, CA, Goff, BA, Lowe, K, et al. Factors affecting risk of mortality in women with vaginal cancer. Obstet Gynecol 2009; 113: 1038–1045.
Google Scholar | Crossref | Medline3. Creasman, WT, Phillips, JL, Menck, HR. The National Cancer Data Base report on cancer of the vagina. Cancer 1998; 83: 1033–1040.
Google Scholar | Crossref | Medline4. Alemany, L, Saunier, M, Tinoco, L, et al; HPV VVAP study group . Large contribution of human papillomavirus in vaginal neoplastic lesions: a worldwide study in 597 samples. Eur J Cancer 2014; 50: 2846–2854.
Google Scholar | Crossref | Medline5. Adams, TS, Cuello, MA. Cancer of the vagina. Int J Gynaecol Obstet 2018; 143: 14–21.
Google Scholar | Crossref | Medline6. Kirkbride, P, Fyles, A, Rawlings, GA, et al. Carcinoma of the vagina: experience at the Princess Margaret Hospital (1974-1989). Gynecol Oncol 1995; 56: 435–443.
Google Scholar | Crossref | Medline7. Gadducci, A, Carinelli, S, Guerrieri, ME, et al. Melanoma of the lower genital tract: prognostic factors and treatment modalities. Gynecol Oncol 2018; 150: 180–189.
Google Scholar | Crossref | Medline8. Barcellini, A, Gadducci, A, Laliscia, C, et al. Adenoid cystic carcinoma of Bartholin’s gland: what is the best approach? Oncology 2020; 98: 513–519.
Google Scholar | Crossref | Medline9. Stock, RG, Chen, AS, Seski, J. A 30-year experience in the management of primary carcinoma of the vagina: analysis of prognostic factors and treatment modalities. Gynecol Oncol 1995; 56: 45–52.
Google Scholar | Crossref | Medline10. Tjalma, WA, Monaghan, JM, de Barros Lopes, A, et al. The role of surgery in invasive squamous carcinoma of the vagina. Gynecol Oncol 2001; 81: 360–365.
Google Scholar | Crossref | Medline11. Kanayama, N, Isohashi, F, Yoshioka, Y, et al. Definitive radiotherapy for primary vaginal cancer: correlation between treatment patterns and recurrence rate. J Radiat Res 2015; 56: 346–353.
Google Scholar | Crossref | Medline12. Orton, A, Boothe, D, Williams, N, et al. Brachytherapy improves survival in primary vaginal cancer. Gynecol Oncol 2016; 141: 501–506.
Google Scholar | Crossref | Medline13. Yang, J, Delara, R, Magrina, J, et al. Management and outcomes of primary vaginal cancer. Gynecol Oncol 2020; 159: 456–463.
Google Scholar | Crossref | Medline14. Dimopoulos, JC, Schmid, MP, Fidarova, E, et al. Treatment of locally advanced vaginal cancer with radiochemotherapy and magnetic resonance image-guided adaptive brachytherapy: dose-volume parameters and first clinical results. Int J Radiat Oncol Biol Phys 2012; 82: 1880–1888.
Google Scholar | Crossref | Medline15. Westerveld, H, Schmid, MP, Nout, RA, et al. Image-guided adaptive brachytherapy (IGABT) for primary vaginal cancer: results of the International Multicenter RetroEMBRAVE Cohort Study. Cancers 2021; 13: 1459.
Google Scholar | Crossref | Medline16. Nanavati, PJ, Fanning, J, Hilgers, RD, et al. High-dose-rate brachytherapy in primary stage I and II vaginal cancer. Gynecol Oncol 1993; 51: 67–71.
Google Scholar | Crossref | Medline17. Dalrymple, JL, Russell, AH, Lee, SW, et al. Chemoradiation for primary invasive squamous carcinoma of the vagina. Int J Gynecol Cancer 2004; 14: 110–117.
Google Scholar | Crossref | Medline18. Miyamoto, DT, Viswanathan, AN. Concurrent chemoradiation for vaginal cancer. PLoS One 2013; 8: e65048.
Google Scholar | Crossref | Medline19. Samant, R, Lau, B, Choan, E, et al. Primary vaginal cancer treated with concurrent chemoradiation using Cis-platinum. Int J Radiat Oncol Biol Phys 2007; 69: 746–750.
Google Scholar | Crossref | Medline20. Kunos, CA . Therapeutic mechanisms of treatment in cervical and vaginal cancer. Oncol Hematol Rev 2012; 8: 55–60.
Google Scholar | Medline21. Murakami, N, Kasamatsu, T, Sumi, M, et al. Radiation therapy for primary vaginal carcinoma. J Radiat Res 2013; 54: 931–937.
Google Scholar | Crossref | Medline22. Rubin, SC, Young, J, Mikuta, JJ. Squamous carcinoma of the vagina: treatment, complications, and long-term follow-up. Gynecol Oncol 1985; 20: 346–353.
Google Scholar | Crossref | Medline23. Hellman, K, Lundell, M, Silfverswärd, C, et al. Clinical and histopathologic factors related to prognosis in primary squamous cell carcinoma of the vagina. Int J Gynecol Cancer 2006; 16: 1201–1211.
Google Scholar | Crossref | Medline24. FIGO Committee on Gynecologic Oncology . Current FIGO staging for cancer of the vagina, fallopian tube, ovary, and gestational trophoblastic neoplasia. Int J Gynaecol Obstet 2009; 105: 3–4.
Google Scholar | Crossref | Medline25. Bentzen, SM, Constine, LS, Deasy, JO, et al. Quantitative Analyses of Normal Tissue Effects in the Clinic (QUANTEC): an introduction to the scientific issues. Int J Radiat Oncol Biol Phys 2010; 76: S3–S9.
Google Scholar | Crossref | Medline26. Rajagopalan, MS, Xu, KM, Lin, JF, et al. Adoption and impact of concurrent chemoradiation therapy for vaginal cancer: a National Cancer Data Base (NCDB) study. Gynecol Oncol 2014; 135: 495–502.
Google Scholar | Crossref | Medline27. Kirchheiner, K, Fidarova, E, Nout, RA, et al. Radiation-induced morphological changes in the vagina. Strahlenther Onkol 2012; 188: 1010–1017.
Google Scholar | Crossref | Medline28. Hiniker, SM, Roux, A, Murphy, JD, et al. Primary squamous cell carcinoma of the vagina: prognostic factors, treatment patterns, and outcomes. Gynecol Oncol 2013; 131: 380–385.
Google Scholar | Crossref | Medline29. Westerveld, H, Nesvacil, N, Fokdal, L, et al. Definitive radiotherapy with image-guided adaptive brachytherapy for primary vaginal cancer. Lancet Oncol 2020; 21: e157–e167.
Google Scholar | Crossref | Medline30. Schmid, MP, Franckena, M, Kirchheiner, K, et al. Distant metastasis in patients with cervical cancer after primary radiotherapy with or without chemotherapy and image guided adaptive brachytherapy. Gynecol Oncol 2014; 133: 256–262.
Google Scholar | Crossref | Medline31. Tanderup, K, Fokdal, LU, Sturdza, A, et al. Effect of tumor dose, volume and overall treatment time on local control after radiochemotherapy including MRI guided brachytherapy of locally advanced cervical cancer. Radiother Oncol 2016; 120: 441–446.
Google Scholar | Crossref | Medline32. Pötter, R, Tanderup, K, Schmid, MP, et al; EMBRACE Collaborative Group . MRI-guided adaptive brachytherapy in locally advanced cervical cancer (EMBRACE-I): a multicentre prospective cohort study. Lancet Oncol 2021; 22: 538–547.
Google Scholar | Crossref | Medline33. Laliscia, C, Gadducci, A, Fabrini, MG, et al. Definitive radiotherapy for primary squamous cell carcinoma of the vagina: are high-dose external beam radiotherapy and high-dose-rate brachytherapy boost the best treatment? Experience of two Italian institutes. Oncol Res Treat 2017; 40: 697–701.
Google Scholar | Crossref | Medline